WASHINGTON - A drug manufacturer asked the Supreme Court on Friday to preserve access to its abortion drug free from restrictions imposed by lower court rulings, while a legal fight continues.Danco Laboratories filed its emergency request with the high court less than two days after an appeals court ruling in a case from Texas that had the effect of tightening the rules under which the drug, mifepristone, can be prescribed and dispensed.The new limits would take effect Saturday unless the court acts before then.The fight over mifepristone lands at the Supreme Court less than a year after conservative justices reversed Roe v.
Wade and allowed more than a dozen states to effectively ban abortion outright.An appeal from the Biden administration also is expected.The abortion drug Mifepristone, also known as RU486, is pictured in an abortion clinic February 17, 2006 in Auckland, New Zealand.
The drug, which has been available in New Zealand for four years and is used in many countries around the world, is exp Danco, , based in New York, asked the court for a temporary order to keep in place Food and Drug Administration regulations governing mifepristone.
Such an order would give the justices time to more fully consider each side’s arguments without the pressure of a deadline.A ruling from the 5th U.S.